Release Date: December 23, 2020
Expiration Date: December 23, 2021

Target Audience:

This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with CSID.

Educational Objectives:

After completing this program, participants should be better able to:

  • Describe the role of intestinal disaccharidases in pediatric health and disease.
  • Summarize recent evidence regarding the epidemiology, presentation, and natural history of pediatric patients with CSID
  • Incorporate practical screening/diagnostic strategies to identify appropriate pediatric patients for screening, interpret test results accurately, and effectively differentiate CSID from other common GI disorders seen in clinical practice
  • Describe the role of dietary modification and enzyme supplementation in the management of pediatric patients with CSID

Accreditation Statement and Credit Designation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and the GI Health Foundation. RMCHCS is accredited by the NMMS to provide continuing medical education to physicians.

RMCHCS designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Accredited by

Provided by

Supported by an educational grant from QOL Medical, LLC.

Presented for attendees of the NASPGHAN Annual Meeting. This event is sponsored by the GI Health Foundation and supported by QOL Medical, LLC. This is not an official NASPGHAN event/function.

For more information, visit www.GiHealthFoundation.org, email info@GiHealthFoundation.org or call 877-782-4532

Congential Sucrase
Isomaltase Deficiency (CSID):
The Tried, the True, and the New

FEATURED FACULTY

(Select a faculty member to view their full bio)

AGENDA

Introduction and Late-Breaking News

The Ins and Outs of Intestinal Disaccharidases

Sucrase-Isomaltase Deficiency: Clinical Presentation, Diagnosis, and Treatment

Challenging the Paradigm of IBS: Not All Pains Are Created Equal

Panel Discussion and Extended Q&A

Closing Remarks

MIGUEL SAPS, MD (CHAIR)

The George E. Batchelor Chair in Pediatrics
Professor of Pediatrics, University of Miami, Miller School of Medicine
Chief of the Division of Pediatric Gastroenterology, Hepatology, and Nutrition
Miami, FL

TBD

SPEAKER DISCLOSURES:

Consultant : Allergan
Scientific Advisory Board : Innovative Health Solutions

TANAZ F. DANIALIFAR, MD

Assistant Professor
Pediatric Gastroenterology, Hepatology, and Nutrition
Children's Hospital Los Angeles
Los Angeles, CA

TBD

SPEAKER DISCLOSURES:

Consultant: QOL Medical, LLC.
Speaker: QOL Medical, LLC.

CRAIG A. FRIESEN, MD

Pediatric Gastroenterology
Division Director, Gastroenterology
Medical Director of Abdominal Pain Program
Professor of Pediatrics, University of Missouri-Kansas City School of Medicine
Clinical Professor of Pediatrics, University of Kansas School of Medicine
Kansas City, MO

TBD

SPEAKER DISCLOSURES:

Consultant: Allakos